If you and your gastroenterologist decide to move forward, a few strategies can help reduce the risk: Start low and go slow
FDA approved the oral antiviral Ritonavir, Nirmatrelvir (Paxlovid) (Nirmatrelvir tablets and Ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death
Amy Myers
However, some peptide researchers explore combining GLP-1 agonists with non-overlapping peptides that target different pathways
By modulating these neural pathways, both medications significantly reduce food cravings and emotional eating patterns
Reach out to your healthcare provider to see if an alternative method of birth control or different medication might be a better fit. Advertisement Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more